documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
18 rows where docket_id = "FDA-2006-P-0025" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, last_modified, posted_date (date), comment_start_date (date), last_modified (date)
document_type 2
agency_id 1
- FDA 18
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2006-P-0025-0017 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | FDA/CDER Response to Sanofi Aventis US LLC - Petition Denial | Other | PDN-Petition Denial | 2009-07-11T04:00:00Z | 2009 | 7 | 2009-07-11T04:00:00Z | 2009-07-11T09:05:04Z | 0 | 0 | 09000064809eede3 | ||
| FDA-2006-P-0025-0018 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | ICH Harmonised Tripartite Guidelines "Impurities in New Drug Products Q3B(R2)" - [Sanofi-aventis U.S., LLC (sanofi-aventis) - Petition Supplement(2)] | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2009-07-11T04:00:00Z | 2009 | 7 | 2009-07-11T09:15:59Z | 0 | 0 | 0900006480971bb1 | |||
| FDA-2006-P-0025-0016 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis U.S., LLC (sanofi-aventis) - Petition Supplement(2) | Other | SUP-Supplement | 2009-05-14T04:00:00Z | 2009 | 5 | 2009-05-14T04:00:00Z | 2013-08-11T01:27:14Z | 0 | 0 | 090000648096ea74 | ||
| FDA-2006-P-0025-0011 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Appendix B - sanofi-aventis Analytical Study Report: Analytical Assessment of Oxaliplatin Solutions Containing Tartaric Acid | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:41Z | 0 | 0 | 0900006480441f20 | |||
| FDA-2006-P-0025-0007 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Reference 32 - U.S. Patent No. 6,476,068 | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:37Z | 0 | 0 | 0900006480441f02 | |||
| FDA-2006-P-0025-0009 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Appendix A - Declarations of Professor Stephen Chaney | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:39Z | 0 | 0 | 0900006480441f1c | |||
| FDA-2006-P-0025-0008 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Reference 31 - U.S. Patent No. 6,673,805 | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:38Z | 0 | 0 | 0900006480441f03 | |||
| FDA-2006-P-0025-0015 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis U.S LLC - Appendix B - Supplemental Declaration of Stephen G. Chaney, Ph.D. | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T16:04:27Z | 0 | 0 | 0900006480441f34 | |||
| FDA-2006-P-0025-0005 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Reference 34 Mayne Pharma. Pty. LTD, et al. U.S. Patent Application No. WO/2005/020980 A1 (filed Oct. 03, 2005). | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:34Z | 0 | 0 | 0900006480441efc | |||
| FDA-2006-P-0025-0010 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Appendix A - Declarations of Professor Nicholas Fartell | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:40Z | 0 | 0 | 0900006480441f1f | |||
| FDA-2006-P-0025-0012 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis U.S LLC - Citizen Petition Supplement | Other | SUP-Supplement | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T05:00:00Z | 2008-11-17T16:03:59Z | 0 | 0 | 0900006480441f35 | ||
| FDA-2006-P-0025-0006 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Reference 33 - U.S. Patent Application Publication No. US 2003/0109515 A1, Jun. 12, 2003 | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T15:35:35Z | 0 | 0 | 0900006480441efd | |||
| FDA-2006-P-0025-0004 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis US LLP - Citizen Petition | Other | CP-Citizen Petition | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T05:00:00Z | 2009-07-11T09:01:35Z | 0 | 0 | 0900006480441f1b | ||
| FDA-2006-P-0025-0014 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis U.S LLC - Appendix B - Supplemental Declaration of Nichola s P. Farrell, Ph.D. | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T16:04:25Z | 0 | 0 | 0900006480441f33 | |||
| FDA-2006-P-0025-0013 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | Sanofi-aventis U.S LLC - U.S. Patent Application 20070054957 | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2008-11-17T05:00:00Z | 2008 | 11 | 2008-11-17T16:04:24Z | 0 | 0 | 0900006480441f25 | |||
| FDA-2006-P-0025-0003 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | FDA/CDER to Sanofi Aventis US LLC | Other | LET-Letter | 2007-06-25T04:00:00Z | 2007 | 6 | 2008-04-11T23:17:23Z | 0 | 0 | 0900006480441f36 | |||
| FDA-2006-P-0025-0002 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | FDA/DDM to Sanofi-aventis US LLP | Other | ACK-Acknowledgement Letter | 2006-12-19T05:00:00Z | 2006 | 12 | 2008-04-11T23:17:24Z | 0 | 0 | 0900006480441f21 | |||
| FDA-2006-P-0025-0001 | FDA | Require ANDA Applicant for Generic of Eloxatin Solution as Reference Drug to Perform Clinical Testing-CLOSED FDA-2006-P-0025 | FDA/DDM to Sanofi-aventis US LLP | Other | ACK-Acknowledgement Letter | 2006-12-19T05:00:00Z | 2006 | 12 | 2008-04-11T23:17:24Z | 0 | 0 | 0900006480441ef8 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);